Open access peer-reviewed chapter - ONLINE FIRST

Biomaterial in Microencapsulation: How Microencapsulation is Changing the Medicine World

Written By

Arezou Pezhman

Submitted: 12 February 2024 Reviewed: 20 February 2024 Published: 24 May 2024

DOI: 10.5772/intechopen.1005202

Biomaterials in Microencapsulation IntechOpen
Biomaterials in Microencapsulation Edited by Ashutosh Sharma

From the Edited Volume

Biomaterials in Microencapsulation [Working Title]

Dr. Ashutosh Sharma

Chapter metrics overview

18 Chapter Downloads

View Full Metrics

Abstract

Stem cell therapy is one of the novel treatment. Cells possess self-renewal ability and the potential to differentiate into multiple lineages. Cell therapy has been studied in treatment of various diseases and injuries, such as cardiovascular diseases, brain disorders, musculoskeletal defects, osteoarthritis, and skin diseases. The application of cells can be a big challenge in treatment, and they die during transplants because of the unfavorable environments of injured or damaged tissues. A supportive environment can help cell survival, induce bio-activity, and enhance cell retention at the administered sites. Stem cell microencapsulation in biocompatible biomaterials can be a good supportive environment that lets cells grow properly. In this review, we discuss about new materials, their application for microencapsulation and how these materials can alter drug delivery and treatment of diseases. New natural and artificial materials optimize microencapsulation application and can be a novel solution for what scientist struggle with.

Keywords

  • biomaterial
  • stem cell
  • tissue engineering
  • drug delivery
  • hydrogel

1. Introduction

Stem cell therapy and biomaterial for drug delivery as novel therapies have recently offered new opportunities in clinical applications that permitted more precise and early diagnoses, less invasive and quicker procedures, and fewer and stay hospital visits. Stem cell therapy has been performed to treat various diseases and injuries, such as cardiovascular diseases, osteoarthritis, brain, neural, and musculoskeletal disorders [1, 2, 3, 4]. Stem cells are capable of renewing themselves and have the potential to differentiate into multiple lineages, which include pluripotent stem cells, such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and multipotent stem cells such as hemopoietic stem cells (HSC), mesenchymal stem cells (MSCs), and adult stem cells (ASCs). Cell encapsulation is based on the immobilization of cells in favorable with synergistic intercellular interactions without being washed out or damaged due to the surrounding shear forces. Cell encapsulation technology can protect cells from hydrodynamic pressure and cell aggregation while allowing for the functional diffusion of nutrients, growth factors, and gases through the microcapsule matrix [5]. Ideal candidates for encapsulation would be non-immunogenic, non-tumorigenic, easy to access and form, well-specify, and reproducible. A lot of different cell types have been used for encapsulation, each with its unique advantages and limitations [6]. Several materials have been used in cell encapsulation including alginate [7], poly(lactic-co-glycolic acid)/poly(l-lactic acid) scaffolds [8], agarose [9], chitosan [10], poly ethylene glycol [11] and hyaluronic acid [12]. However, natural materials have some limitations, such as hard accessibility, finite source, rapid degradation, weak mechanical properties, and limited processability, which slow their clinical application. Also, the purity degree of some materials determines the biocompatibility of the microcapsules, so the purity degree and viability must be examined well [13]. Microencapsulation can offer a beneficial method of administering therapeutic materials and molecules that cannot be replaced by pharmacological substances, enabling novel solutions for the treatment of many diseases. Some applications of stem cell encapsulation in treatment of disease are listed in Table 1.

Bone [14]
CNS [15]
Cartilage [16]
Cardiovascular [17]
Cancer [18]
Diabetes [19]
Liver [20]
Skin [21]

Table 1.

Application of stem cell.

The long-term viability of microencapsulated cells, rate of polymer membrane degradation, pericapsular fibrosis formation tendency, and potential risk of immunogenicity to the polymers remain big challenges in microencapsulation. The encapsulating polymer must provide a barrier to prevent the immune system from recognizing the foreign cells [22]. A good material used for encapsulation should not interfere with the host cell’s homeostasis. The direct side effect of a non-compatible material is type 1 hypersensitivity reaction, which is a non-specific body reaction that starts with the non-specific absorption of macrophages to the implant site [23]. The permeability of materials is one of the important features of encapsulation. The microcapsule membrane must have an appropriate pore size to supply essential nutrients necessary for cell survival, and it must also have enough immunoprotection to forbid contact with host immune cells [6]. Mechanical resistance of a material is critical to ensure cell immunoprotection and molecule release time period define the deformation and rupture of the capsules under external load [24]. There are some methods and techniques for microencapsulation application, as highlighted in Table 2 [25].

Mechanical (physical) methods
Solvent evaporation
Spray drying
Droplet freezing
Airflow or fluidized bed
Droplet gelation
Centrifugation
Extrusion
Chemical methods
In situ and interfacial polycondensation
Polymerization
Gelation
Physicochemical methods
Methods using supercritical fluid
Methods using emulsification
Coacervation
Thermal gelation

Table 2.

Methods for microencapsulation.

Chemical methods of microencapsulation include solvent evaporation, interfacial crosslinking, interfacial polycondensation, in situ polymerization, and matrix polymerization which usually undergo heat reduction after mixing and heating [26]. Physical methods include spray drying, fluid-bed/pan coating, centrifugal extrusion, vibrating nozzle, and spinning disk microencapsulation. The dispersion of an oil core material or water-soluble active ingredient into a concentrated coating material is used to prepare for spray drying [27]. In fluid-bed coating, solid particles are mixed with a dry coating material that is heated to surround the particle cores [28]. The microcapsule core and coating materials are both immiscible with each other, so centrifugal extrusion is pressed into the concentric nozzles, forming a flow that is crushed into droplets following the clearing of the nozzle [25]. The liquid material to be encapsulated is extruded through a nozzle at a specific flow rate in a vibrating nozzle [29]. In a spinning disk, a mixture is configured with the liquid microcapsule coating material and the material for the internal core of the microcapsule [25]. Physicochemical encapsulation techniques involve supercritical fluid technology, coacervation, polyelectrolyte complexation, and ionotropic gelation. Ionotropic gelation works through the polyelectrolyte’s ability to attach when in the presence of counterions, resulting in their gelation [30]. In polyelectrolyte complexation, adding polycations or polyelectrolytes can be used to further improve the mechanical strength and permeability of the gelated beads [25]. Coacervation technique that relies on polymer-polymer incompatibility, addition of a salt or alcohol into the polymeric mixture or modification of the aqueous phase pH, lead to crosslinking of polymers [31]. Supercritical fluid technology is relied on the formation of particles that are monodispersed with the capability to form nanosized particles [32]. A lot of synthetic and natural materials are being used in microencapsulation. Some of these materials and their application are described below.

Advertisement

2. Alginate

Alginates are natural polysaccharides, polyanionic polymers, and unbranched copolymers of d-mannuronic acid and l-guluronic acid linked by β (1-4) glycosidic bonds [33, 34, 35]. Alginate is derived from various species of brown algae cell walls such as hyperborea, Ecklonia maxima, Ascophyllum nodosum, Eisenia bicyclis, Laminaria, Macrocystis pyrifera, etc., and from various species of bacteria: Azotobacter and Pseudomonas [36, 37]. Alginate is a biodegradable and biocompatible polymer with low immunogenicity in human body. Alginate’s ability to form hydrogel makes it a useful material for the delivery of medicines and cellular immobilization [38, 39]. Because of gel and hydrogel-forming of alginate, it can be easily synthesized and manipulated and can control the speed of release of active compounds from pharmaceutical systems [40, 41]. Chemically modified alginic acid, because of its strong polyanions feature, was found to inhibit fibrotic formation after transplantation by inactivating an immune response, while cationic materials tend to induce inflammatory reaction [42]. Alginate helps in treatment of many diseases. Some of the alginate application include intestinal inflammation and colitis in inflammatory bowel disease, diabetes, hemophilia, cancer, renal failure, liver, and musculoskeletal diseases [18, 43, 44, 45, 46, 47]. Also, because of gel-forming properties of alginate, simple structure, simple raw materials, low toxicity, and mild processing, alginate can be a practical material in drug delivery such as probiotic and anticancer drugs [48, 49].

Advertisement

3. Agarose

Agarose, usually derived from red algae and seaweed, includes a galactose-based structure. Its ability to undergo reversible gelation in response to temperature makes it a functional biomaterial for tissue engineering applications [50]. Agarose is thermally responsive [50] and very similar to the extracellular matrix of natural cell, making it suitable for cell encapsulation. Agarose has been used in medical applications widely because of its functional features including controlled self-gelling properties, water solubility, adjustable mechanical properties, non-immunogenic nature and it is biocompatibility [51]. Agarose, based on its stiffness and functional groups, can support cellular adhesion, proliferation, and activity. In tissue engineering, agarose hydrogels were combined with cells and applied for the regeneration of several structures such as cartilage [52], bone [53], tendons [54], neural system [55], cardiac regeneration, wound healing [56] and cornea. The limitation of using agarose is that mammalian cells cannot degrade agarose, so it can affect gene expression and cell phenotype [57].

Advertisement

4. Chitosan

Chitosan is a derivative of the shell waste of crab, shrimp, and crawfish and a polysaccharide composed of (1, 4)-linked 2-amino-deoxy-b-d-glucan [58, 59]. Chitosan coating a unique cationic character, high biocompatibility, non-toxicity, and biodegradability that make it a functional material in the pharmaceutical industry and tissue engineering, improving improved mechanical strength and a strong barrier function [60]. Furthermore, chitosan properties, such as low solubility in water and organic solvents, can be improved by chemical modification. Also, chitosan has great potential to be used in common applications for the preparation of microspheres, nanospheres, and microcapsules. Chitosan is a cationic biopolymer and has intrinsic antimicrobial activity, besides other potentialities like antioxidant, antitumor, and immune modulator, with an effective drug delivery agent. Medical application of chitosan improves disease treatment, especially in cartilage, bone, and nerve repair, and upgrades tissue engineering methods in their treatment [61, 62, 63]. Wound healing, Gene Silencing in Disease Vector Mosquito Larvae, obesity, and cardiovascular disease treatment are other uses of chitosan and derivatives [64, 65, 66, 67]. Chitosan is widely used for drug encapsulation, growth factors, antimicrobials, painkillers, and antitumoral or anti-inflammatory drugs [68, 69, 70, 71, 72]. Also, chitosan and chitosan derivatives show antimicrobial activity against different microorganisms, including bacteria, filamentous fungi, and yeast, that can be a solution in bacterial resistance to antibiotics [73]. One of the important industrial applications of chitosan is its role in water filtering, which helps in the adsorption of pollutants in water [74].

Advertisement

5. Dextran

One of the suitable materials for use as a scaffold in tissue engineering is dextran [75]. Dextran is a neutral, biodegradable polysaccharide formed from sucrose by bacteria. Anti-thrombolytic and bioadhesive properties make it one of the best scaffolds in tissue engineering [76]. Also, a specific characteristic feature of dextran is The active hydroxyl groups of dextran can be chemically modified to incorporate various functional groups, so dextran has been chemically engineered to form various scaffolds, including spheres [77, 78, 79], tubules [80], and hydrogel [81, 82]. Dextran has been used a lot in biomedical and pharmaceutical applications like decreasing vascular thrombosis [83, 84], reducing inflammatory response [85], preventing ischemia-reperfusion injury in organ transplantation [86, 87, 88], promoting wound healing [89, 90], and enhancing chondrogenesis and cartilage regeneration [91]. Due to its excellent physicochemical properties and biocompatibility, dextran has been assumed one of the best materials for drug delivery and transport of therapeutic agents [92, 93].

Advertisement

6. Gellan gum

Gellan gum is one of the best polymers in tissue engineering and drug delivery because of its biodegradability, biocompatibility, and sustainability features [94, 95]. Gellan gum is formulated by bacterial exopolysaccharide fermentation from Pseudomonas elodea or Sphingomonas elodea, negatively charged, and contains linear exopolysaccharides consisting of four repeating carbohydrates in the main chain [96, 97]. Its ability to undergo sol-gel transition and form a solid gel upon contact with cations can be used to prepare drug-loaded matrices [98]. This features make gellan gum a perfect material in tissue engineering and regenerative medicine, such as its wide utilization in cartilage [99, 100, 101], bone [102, 103, 104], osteochondral disorders [105], spinal cord injury [106], wound healing [107], diabetic ulcer [108] and retinal injury [109]. However, native gellan gum has some limitations, requiring high temperature (60–90°C) for water dissolution and high concentration for the production of stable physical hydrogel that limits production procedure and suitability for direct cell encapsulation [110].

Advertisement

7. Matrigel

Matrigel, an extract derived from the EHS (Engelbreth-Holm-Swarm) tumor, contains all of the known major components of many tissue basement membranes that was found by Dr. Engelbreth-Holm from spontaneous mouse tumor. Matrigel contain all of the components present in basement and is very biologically active [111]. The components of Matrigel are four major basement membrane extracellular matrix (ECM) proteins: laminin, collagen IV, entactin, and the heparin sulfate proteoglycan perlecan [112] and also contain collagen I, XVIII, VI [113] and III and tumor-derived proteins, including growth factors, such as fibroblast growth factors (FGFs) and transforming growth factor (TGF) family peptides (for example, TGF-β) [114, 115] and enzymes, such as matrix metalloproteinases (MMPs) [111, 116]. Matrigel undergoes gelation at temperatures in the range of 22–37°C and is used to culture and cell differentiation such as human pluripotent stem cells (hPSCs) [117], neural tissue [118, 119], and cardiomyocytes [120]. Matrigel also has been used for endothelial tubulogenesis [121, 122], an organoid assembly such as inner ear organoid [123], and applied for promoting angiogenesis [124], cell differentiation in tissue engineering [125], and skin repair [126]. Matrigel application is limited because of the presence of xenogenic contaminants [114, 127], so it needs to be used with caution.

Advertisement

8. Gelatin methacrylate

Gelatin methacrylate (GelMA) was developed by modifying the reactive side groups of gelatin using glycidyl methacrylate [128] that allowed photo-crosslinking so as to provide customizable mechanical properties [129]. GelMA can be manufactured through several methods, such as soft lithography [130], electrospray [131], three-dimensional printing [132], microfluidic chip [133], and emulsion [134]. However, UV light exposure during crosslinking can reduce the survival rate of cells and damage organisms [135, 136, 137]. GelMA has a dynamics macromolecular network and biomimic microenvironment that has a high water content [138, 139]. Hydrogels like GelMA are planned to be similar to the characteristics of extracellular matrix (ECM), and three-dimensional (3D) structure supports for cellular growth and tissue formation [140] and also used for cell-cell interactions, proliferation, migration [141], and controlled differentiation [142] in tissue engineering. Biocompatibility, biodegradability and low cost makes GelMA [143] useful in drug delivery [144], cell delivery [145], gene delivery [146], vaccine delivery [147], wound healing [148, 149], and tissue regeneration [150]. Also, GelMA has broad applications in biomedical field such as corneal regeneration [151], bone repair [152, 153], myocardial infarction [154, 155], hemostasis control [156], and vascular regeneration [157, 158].

Advertisement

9. Polyethylene glycol

Polyethylene glycol (PEG) is a product that is used in both industrial and pharmaceutical industries. PEG is a low-toxic, hydrophobic, semicrystalline polyether that is used in drug delivery systems and tissue engineering scaffold formation [159]. Biocompatibility and hydrophilic feature with properties that limit antigenicity, immunogenicity, cell adhesion, and protein binding [160] makes PEG a successful scaffolding material for 3D printing in tissue engineering [161]. The essential molecular structure of PEG is PEG diol surrounded with two hydroxyl end groups, which can be switched into other functional groups such as carboxyl, amine, vinyl sulfane, methoxyl, thiol, azide, acetylene, and acrylate [162, 163]. Photopolymerization is the most common technique to make PEG hydrogel [164]. The photoinduced crosslinking strategy enhances the crosslinking parameters and biocompatibility by functionalizing them with acrylic or methacrylic groups [165]. Photopolymerization can mix synthetic and modified polymers like polyethylene glycol diacrylate (PEGDA) with natural polymers to form a double network hydrogel for better results [166]. Also, synthetic polymers, such as modified PEG, are able to mimic the biochemical properties of proteins [167, 168]. Because of these features, PEG has become impressing material for bone repair, nerve tissue regeneration [169, 170], and bioprinting applications [171].

Advertisement

10. Polycaprolactone

PCL is a semicrystalline aliphatic polyester that is biodegradable, biocompatible, and non-toxic. PCL exhibits excellent chemical and solvent resistance, good toughness, low glass transition (−60°C), and melting temperature (60°C) [172]. The distribution of water molecules into formless regions causing hydrolytic breakdown of ester bonds can degrade PCL, initially in the formless part, followed by the crystal-line domain [173]. PCL has gained lot of importance in the design of biomaterials/green materials in areas like wound dressing, contraceptives, and dentistry, along with nonmedical fields like food, packaging, and environment [174, 175]. Because of PCL’s high permeability to many drugs, excellent biocompatibility, slow biodegradability, and bioresorbability, PCL is used for long-term drug delivery such as anticancer [176, 177], antipsychotic [178], non-steroidal anti-inflammatory [179, 180], anti-hypertensive drugs [181] and, others. PCL is also one of the most common materials in tissue engineering and 3D scaffolds. Polycaprolactone features such as mechanical properties with high flexibility and great elongation make it an excellent material for the preparation of scaffolds for bone repair [182] and wound dressing [183]. 3D-printed medical devices are an advanced application of PCL. PCL airway devices [184], congenital heart defects, gastric wall damage (hollow organ), and periodontal repair are affecting millions of people around the world [185, 186, 187].

11. Polyvinylpyrrolidone

Polyvinylpyrrolidone (PVP) is a hygroscopic, amorphous, synthetic polymer consisting of linear 1-vinyl-2-pyrrolidinone groups [188]. Polyvinylpyrrolidone is a biodegradable, water-soluble polymer that is biocompatible and non-toxic. It also has a stabilizing effect on suspensions and emulsions [189, 190]. PVP is widely used in the food industry, cosmetics, pharmaceutical, and biomedical applications [191, 192] as well as drug delivery such as gene delivery, oral, topical, transdermal, and ocular administration [193, 194, 195]. PVP constitutes a group of crosslinked 3D networks of hydrophilic polymer chains, which are capable of holding large amounts of water without dissolving [196]. PVP structure is similar to living tissues and tissue matrix so that it can be used for the fabrication of tissue engineering coatings and wound dressings, bone and cartilage repairing systems, drug delivery systems, and other body-contacting devices products, such as contact lenses [196, 197, 198]. However, there have been documented cases of allergic reactions to PVP, particularly regarding subcutaneous use and situations where the PVP has come in contact with autologous serum and mucous membranes [199, 200, 201]. Allergic reactions of PVP commonly happen because of conjunction with other chemicals, such as iodine [202].

12. Poly(l-lactic) acid

Polylactic acid (PLA) is a biodegradable material derived from lactic acid (LA) and produced from reproducible origine such as corn, wheat, and straw [203, 204]. PLA is classified as an aliphatic polyester because of the ester bonds that connect the monomer units. It is made by the bacterial fermentation of carbohydrates using optimized strains of the genus Lactobacillus [205]. PLA is not altered by solvent bulging and dissolution during industrial fabrication. Processing temperature is generally 170–230°C, so it is also a proper material for spinning, biaxial stretching, extrusion, and injection blow-molding processing methods [206, 207, 208]. PLA is used as bio-based plastic and reduces plastic-induced environmental problems [209]. PLA has been widely used as a scaffold in tissue engineering. PLA-based scaffold can be manufactured by controlling the related parameters such as crystallinity, molecular weight, copolymer ratio, essential viscosity, and residual monomers to reach the appropriate physical properties so can stimulate isolated cells to regenerate tissues and act as a drug delivery carrier [210, 211]. Also, PLA has got an important role in biomedical applications such as suture threads, bone fixation screws, and devices for drug delivery, just to scratch the surface [212]. In addition to the musculoskeletal tissue engineering application of PLA, it has been used in nervous, cardiovascular, and cutaneous application [213, 214, 215]. The usage of PLA, especially in the biomedical field, is still limited by its low biodegradability and hydrophobicity [216].

13. Poly(lactic-co-glycolic) acid

Poly(lactic-co-glycolic) acid (PLGA) is a copolymer with lactic and glycolic acid repeat units with linear structure, which can be formed as a block-co-polymer or statistical polymer. The body can degrade both monomers into carbon dioxide and water via the Krebs cycle, which could be achieved from the fermentation of corn or other grains, and the glycolic acid part could be created from the biochemical enzymatic reaction or by the chemical combination of chloroacetic acid and sodium hydroxide [217, 218, 219]. Polymer characteristic features, such as degradation kinetics, rheological properties, thermal properties, mechanical properties, water uptake, and release profiles, can be determined by modification of the LA/GA ratio, terminal group, and constructed parameters of PLGA that facilitates the engineering of this polymer. Higher PGA content leads to quicker metabolization rates, with the exception of an equal ratio of PLA/PGA, which shows the fastest degradation rate, while higher PGA substances lead to increased degradation [220]. PLGA metabolizes by hydrolysis of its ester linkages [221]. PLGA can be dissolved by a wide range of popular solvents, such as tetrahydrofuran, chlorinated solvents, acetone or ethyl acetate, though pure polyglycolic acid and polylactic acid show poor solvability [222]. PLGA is an attractive provider of devices for multidrug distribution and multiplication operations. Numerous studies have also reported successful applications in antibiotics, antiseptics, anticancer, and imaging medications [223, 224]. PLGA can be easily processed and fabricated in various forms and sizes as nanoparticles (microspheres, microcapsules, nanocapsules, and nanospheres) [225]. One of the most generally used biodegradable synthetic polymers for 3D scaffolds in tissue engineering is PLGA. PLGA grafts can be embedded with many regenerative factors to boost healing, such as growth factors, stem cells, and drugs, that make them suitable for bone repair and cartilage regeneration [226, 227, 228].

14. Conclusion

The word microcapsules implies the membrane-surrounded particles or droplets distributed in a solid matrix. Microencapsulation has gained importance in the fields of cell and tissue engineering. The encapsulation system provides free exchange of what cells need to grow such as nutrients and oxygen between the loaded cells and their surrounding environment while preventing the removal and elimination of the loaded cells. The choice of an encapsulating agent depends on several factors, such as biocompatibility, processing, physicochemical properties of the substance to be encapsulated, and degradation prevention. Microencapsulation is a functional technology for the immunoprotection of biological material to avoid host immune response and protect cells from immune suppression. Polymeric biomaterial, either of natural or synthetic origin, must have high biocompatibility and biotolerability, similarity to the extracellular matrix (ECM) of human tissues and their composition, that simulate the biological environments of the human body. Also, microencapsulation has become increasingly important in the fields of pharmaceutical engineering and improved drug delivery systems. Microencapsulation technology has developed industrial materials such as food industry. In fact, microencapsulation can be a good solution to face the problem that we struggle with. This technology can help to cure many diseases, upgrade treatment, and reduce complications and treatment costs. Microencapsulation can provide better drug delivery with lower complications and side effects. Also, a new method of microencapsulation can promote potential and profitability in the industry. Choosing the right material and its properties is important to get maximal utilization. Furthermore, the combination of materials increases its potential. Two main groups of microencapsulation materials are natural and synthetic. Natural materials have high biocompatibility, degradability, and similarity to human extracellular matrix (ECM) but have limited sources and harder accessibility. In spite of natural material privileges, synthetic materials are preferred because of easy manufacturing, unlimited accessibility, and good results in medical applications. The best result can be reached by choosing the appropriate material.

15. Future perspective

Nowadays, in spite of all developments in the medical field, humans suffer from disease side effects. Microencapsulation can be a novel way to overcome disease treatment challenges. Microencapsulation with or without biocontent can accelerate healing and minimize side effects. However, microencapsulation is a novel technique, and there is a long way to go to find its place as a routine medical application. By exploring and inventing new material, new instruction, and application methods, we can accelerate microencapsulation usage in all medical fields.

References

  1. 1. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451(7181):937-942
  2. 2. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YRV, Fang SCY, et al. Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134(7):2111-2121. e3
  3. 3. Crevensten G, Walsh AJ, Ananthakrishnan D, Page P, Wahba GM, Lotz JC, et al. Intervertebral disc cell therapy for regeneration: Mesenchymal stem cell implantation in rat intervertebral discs. Annals of Biomedical Engineering. 2004;32:430-434
  4. 4. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. International Journal of Rheumatic Diseases. 2011;14(2):211-215
  5. 5. Zimmermann H, Wählisch F, Baier C, Westhoff M, Reuss R, Zimmermann D, et al. Physical and biological properties of barium cross-linked alginate membranes. Biomaterials. 2007;28(7):1327-1345
  6. 6. Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Advanced Drug Delivery Reviews. 2000;42(1-2):29-64
  7. 7. Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials. 2008;29(29):3946-3952
  8. 8. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proceedings of the National Academy of Sciences. 2003;100(22):12741-12746
  9. 9. Dang S. Scalable bioprocess for controlled differentiation of embryonic stem cells to hematopoietic progenitors. 2004
  10. 10. Li Z, Leung M, Hopper R, Ellenbogen R, Zhang M. Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials. 2010;31(3):404-412
  11. 11. Siltanen C, Diakatou M, Lowen J, Haque A, Rahimian A, Stybayeva G, et al. One step fabrication of hydrogel microcapsules with hollow core for assembly and cultivation of hepatocyte spheroids. Acta Biomaterialia. 2017;50:428-436
  12. 12. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences. 2007;104(27):11298-11303
  13. 13. Orive G, Ponce S, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials. 2002;23(18):3825-3831
  14. 14. Yang L, Liu Y, Sun L, Zhao C, Chen G, Zhao Y. Biomass microcapsules with stem cell encapsulation for bone repair. Nano-micro Letters. 2021;14(1):4
  15. 15. Lopez-Mendez TB, Santos-Vizcaino E, Pedraz JL, Hernandez RM, Orive G. Cell microencapsulation technologies for sustained drug delivery: Clinical trials and companies. Drug Discovery Today. 2021;26(3):852-861
  16. 16. Liu Y, Wang M, Luo Y, Liang Q , Yu Y, Chen F, et al. Enhancing stem cell therapy for cartilage repair in osteoarthritis-A hydrogel focused approach. Gels (Basel, Switzerland). 2021;7(4):263
  17. 17. Karpov AA, Puzanov MV, Ivkin DY, Krasnova MV, Anikin NA, Docshin PM, et al. Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells. International Journal of Experimental Pathology. 2019;100(2):102-113
  18. 18. Shah K. Encapsulated stem cells for cancer therapy. Biomatter. 2013;3(1):1-7
  19. 19. Neumann M, Arnould T, Su B-L. Encapsulation of stem-cell derived β-cells: A promising approach for the treatment for type 1 diabetes mellitus. Journal of Colloid and Interface Science. 2023;636:90-102
  20. 20. Liu P, Mao Y, Xie Y, Wei J, Yao J. Stem cells for treatment of liver fibrosis/cirrhosis: Clinical progress and therapeutic potential. Stem Cell Research & Therapy. 2022;13(1):356
  21. 21. Moyer HR, Kinney RC, Singh KA, Williams JK, Schwartz Z, Boyan BD. Alginate microencapsulation technology for the percutaneous delivery of adipose-derived stem cells. Annals of Plastic Surgery. 2010;65(5):497-503
  22. 22. Marikar SN, El-Osta A, Johnston A, Such G, Al-Hasani K. Microencapsulation-based cell therapies. Cellular and Molecular Life Sciences. 2022;79(7):351
  23. 23. Anderson JM. Inflammatory response to implants. ASAIO Transactions. 1988;34(2):101-107
  24. 24. Sanz Nogués C, Thomas D, Pandit A, O’Brien T. Stem Cell Microencapsulation for Therapeutic Angiogenesis. United States: CRC Press; 2013. pp. 386-424
  25. 25. Tomaro-Duchesneau C, Saha S, Malhotra M, Kahouli I, Prakash S. Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells, and other biopharmaceutics: Current status and future directions. Journal of Pharmaceutics. 2013;2013:103527
  26. 26. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. International Journal of Pharmaceutics. 2008;363(1-2):26-39
  27. 27. Mok H, Park TG. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. European Journal of Pharmaceutics and Biopharmaceutics. 2008;70(1):137-144
  28. 28. Singh M, Hemant K, Ram M, Shivakumar H. Microencapsulation: A promising technique for controlled drug delivery. Research in Pharmaceutical Sciences. 2010;5(2):65
  29. 29. Haas PA. Formation of uniform liquid drops by application of vibration to laminar jets. Industrial & Engineering Chemistry Research. 1992;31(3):959-967
  30. 30. Patil J, Kamalapur M, Marapur S, Kadam D. Ionotropic gelation and polyelectrolyte complexation: The novel techniques to design hydrogel particulate sustained, modulated drug delivery system: A review. Digest Journal of Nanomaterials and Biostructures. 2010;5(1):241-248
  31. 31. Mohanty B, Bohidar H. Systematic of alcohol-induced simple coacervation in aqueous gelatin solutions. Biomacromolecules. 2003;4(4):1080-1086
  32. 32. Yeo S-D, Kiran E. Formation of polymer particles with supercritical fluids: A review. The Journal of Supercritical Fluids. 2005;34(3):287-308
  33. 33. Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Development and Industrial Pharmacy. 2002;28(6):621-630
  34. 34. Van Vlierberghe S, Graulus G-J, Samal SK, Van Nieuwenhove I, Dubruel P. Porous hydrogel biomedical foam scaffolds for tissue repair. In: Biomedical Foams for Tissue Engineering Applications. Sawston, Cambridge: Elsevier; 2014. pp. 335-390
  35. 35. Asgari S, Pourjavadi A, Licht TR, Boisen A, Ajalloueian F. Polymeric carriers for enhanced delivery of probiotics. Advanced Drug Delivery Reviews. 2020;161:1-21
  36. 36. Phillips GO, Williams PA. Handbook of Hydrocolloids. Amsterdam, Netherlands: Elsevier; 2009
  37. 37. Sachan NK, Pushkar S, Jha A, Bhattcharya A. Sodium alginate: The wonder polymer for controlled drug delivery. Journal of Pharmacy Research. 2009;2(8):1191-1199
  38. 38. Sellimi S, Younes I, Ayed HB, Maalej H, Montero V, Rinaudo M, et al. Structural, physicochemical and antioxidant properties of sodium alginate isolated from a Tunisian brown seaweed. International Journal of Biological Macromolecules. 2015;72:1358-1367
  39. 39. Agüero L, Zaldivar-Silva D, Peña L, Dias ML. Alginate microparticles as oral colon drug delivery device: A review. Carbohydrate Polymers. 2017;168:32-43
  40. 40. Ning H, Lu L, Xu J, Lu L, Pan L, Lin Z. Development of sodium alginate-based antioxidant and antibacterial bioactive films added with IRMOF-3/carvacrol. Carbohydrate Polymers. 2022;292:119682
  41. 41. Pawar SN, Edgar KJ. Alginate derivatization: A review of chemistry, properties and applications. Biomaterials. 2012;33(11):3279-3305
  42. 42. Bhatia SR, Khattak SF, Roberts SC. Polyelectrolytes for cell encapsulation. Current Opinion in Colloid & Interface Science. 2005;10(1-2):45-51
  43. 43. Pi Y, Zhang X, Wu Y, Wang Z, Bai Y, Liu X, et al. Alginate alleviates dextran sulfate sodium-induced colitis by promoting bifidobacterium animalis and intestinal hyodeoxycholic acid synthesis in mice. Microbiology Spectrum. 2022;10(6):e02979-e02922
  44. 44. Basta G, Montanucci P, Calafiore R. Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progress. Journal of Diabetes Investigation. 2021;12(3):301-309
  45. 45. Chen Z, Hu Q , Gu Z. Leveraging engineering of cells for drug delivery. Accounts of Chemical Research. 2018;51(3):668-677
  46. 46. Doré E, Legallais C. A new concept of bioartificial liver based on a fluidized bed bioreactor. Therapeutic Apheresis: Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis. 1999;3(3):264-267
  47. 47. Khatab S, Leijs MJ, van Buul G, Haeck J, Kops N, Nieboer M, et al. MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study. Cell Biology and Toxicology. 2020;36(6):553-570
  48. 48. Wang X, Gao S, Yun S, Zhang M, Peng L, Li Y, et al. Microencapsulating alginate-based polymers for probiotics delivery systems and their application. Pharmaceuticals (Basel, Switzerland). 2022;15(5):644
  49. 49. He L, Shang Z, Liu H, Yuan ZX. Alginate-based platforms for cancer-targeted drug delivery. BioMed Research International. 2020;2020:1487259
  50. 50. Zarrintaj P, Manouchehri S, Ahmadi Z, Saeb MR, Urbanska AM, Kaplan DL, et al. Agarose-based biomaterials for tissue engineering. Carbohydrate Polymers. 2018;187:66-84
  51. 51. Irastorza-Lorenzo A, Sánchez-Porras D, Ortiz-Arrabal O, de Frutos MJ, Esteban E, Fernández J, et al. Evaluation of marine agarose biomaterials for tissue engineering applications. International Journal of Molecular Sciences. 2021;22(4):1923
  52. 52. Salati MA, Khazai J, Tahmuri AM, Samadi A, Taghizadeh A, Taghizadeh M, et al. Agarose-based biomaterials: Opportunities and challenges in cartilage tissue engineering. Polymers. 2020;12(5):1150
  53. 53. Hasan ML, Padalhin AR, Kim B, Lee BT. Preparation and evaluation of BCP-CSD-agarose composite microsphere for bone tissue engineering. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2019;107(7):2263-2272
  54. 54. González-Quevedo D, Díaz-Ramos M, Chato-Astrain J, Sánchez-Porras D, Tamimi I, Campos A, et al. Improving the regenerative microenvironment during tendon healing by using nanostructured fibrin/agarose-based hydrogels in a rat Achilles tendon injury model. The Bone & Joint Journal. 2020;102-b(8):1095-1106
  55. 55. Stokols S, Sakamoto J, Breckon C, Holt T, Weiss J, Tuszynski MH. Templated agarose scaffolds support linear axonal regeneration. Tissue Engineering. 2006;12(10):2777-2787
  56. 56. Miguel SP, Ribeiro MP, Brancal H, Coutinho P, Correia IJ. Thermoresponsive chitosan–agarose hydrogel for skin regeneration. Carbohydrate Polymers. 2014;111:366-373
  57. 57. Bissell MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: Is structure the message? Journal of Cell Science Supplement. 1987;8:327-343
  58. 58. Anal AK, Singh H. Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends in Food Science & Technology. 2007;18(5):240-251
  59. 59. Aider M. Chitosan application for active bio-based films production and potential in the food industry. LWT-Food Science and Technology. 2010;43(6):837-842
  60. 60. Heidebach T, Först P, Kulozik U. Microencapsulation of probiotic cells for food applications. Critical Reviews in Food Science and Nutrition. 2012;52(4):291-311
  61. 61. Chameettachal S, Murab S, Vaid R, Midha S, Ghosh S. Effect of visco-elastic silk–chitosan microcomposite scaffolds on matrix deposition and biomechanical functionality for cartilage tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2017;11(4):1212-1229
  62. 62. Li Q , Zhou G, Yu X, Wang T, Xi Y, Tang Z. Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres. Biomedical Engineering Online. 2015;14(1):1-15
  63. 63. Jian R, Yixu Y, Sheyu L, Jianhong S, Yaohua Y, Xing S, et al. Repair of spinal cord injury by chitosan scaffold with glioma ECM and SB 216763 implantation in adult rats. Journal of Biomedical Materials Research Part A. 2015;103(10):3259-3272
  64. 64. Rhoades J, Roller S. Antimicrobial actions of degraded and native chitosan against spoilage organisms in laboratory media and foods. Applied and Environmental Microbiology. 2000;66(1):80-86
  65. 65. Zhang X, Mysore K, Flannery E, Michel K, Severson DW, Zhu KY, et al. Chitosan/interfering RNA nanoparticle mediated gene silencing in disease vector mosquito larvae. JoVE (Journal of Visualized Experiments). 2015;97:e52523
  66. 66. Heber D. Herbal preparations for obesity: Are they useful? Primary Care: Clinics in Office Practice. 2003;30(2):441-463
  67. 67. Yu Y, Luo T, Liu S, Song G, Han J, Wang Y, et al. Chitosan oligosaccharides attenuate atherosclerosis and decrease non-HDL in ApoE−/−mice. Journal of Atherosclerosis and Thrombosis. 2015;22(9):926-941
  68. 68. Zeng W, Chang Z, Liu Z, Zhu L, Wang M, Hao D, et al. Controlled delivery of bioactive BDNF for potential treatment of peripheral nerve injury. Polymer Degradation and Stability. 2020;181:109296
  69. 69. Khare T, Mahalunkar S, Shriram V, Gosavi S, Kumar V. Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli. Environmental Research. 2021;199:111321
  70. 70. Basu SK, Kavitha K, Rupeshkumar M. Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride. AAPS PharmSciTech. 2011;12:28-34
  71. 71. Dawoud M. Chitosan coated solid lipid nanoparticles as promising carriers for docetaxel. Journal of Drug Delivery Science and Technology. 2021;62:102409
  72. 72. Öztürk AA, Kıyan HT. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay. Microvascular Research. 2020;128:103961
  73. 73. Raafat D, Sahl HG. Chitosan and its antimicrobial potential–a critical literature survey. Microbial Biotechnology. 2009;2(2):186-201
  74. 74. Vakili M, Rafatullah M, Salamatinia B, Abdullah AZ, Ibrahim MH, Tan KB, et al. Application of chitosan and its derivatives as adsorbents for dye removal from water and wastewater: A review. Carbohydrate Polymers. 2014;113:115-130
  75. 75. El-Meliegy E, Abu-Elsaad NI, El-Kady AM, Ibrahim MA. Improvement of physico-chemical properties of dextran-chitosan composite scaffolds by addition of nano-hydroxyapatite. Scientific Reports. 2018;8(1):12180
  76. 76. Goyal S, Hernández NB, Cochran EW. An update on the future prospects of glycerol polymers. Polymer International. 2021;70(7):911-917
  77. 77. Franssen O, Vandervennet L, Roders P, Hennink WE. Degradable dextran hydrogels: Controlled release of a model protein from cylinders and microspheres. Journal of Controlled Release: Official Journal of the Controlled Release Society. 1999;60(2-3):211-221
  78. 78. Liebert T, Hornig S, Hesse S, Heinze T. Nanoparticles on the basis of highly functionalized dextrans. Journal of the American Chemical Society. 2005;127(30):10484-10485
  79. 79. Long L-x, Yuan X-b, Chang J, Zhang Z-h, Gu M-q, Song T-t, et al. Self-assembly of polylactic acid and cholesterol-modified dextran into hollow nanocapsules. Carbohydrate Polymers. 2012;87(4):2630-2637
  80. 80. Sun G, Chu CC. Self-assembly of chemically engineered hydrophilic dextran into microscopic tubules. ACS Nano. 2009;3(5):1176-1182
  81. 81. Sun G, Shen YI, Ho CC, Kusuma S, Gerecht S. Functional groups affect physical and biological properties of dextran-based hydrogels. Journal of Biomedical Materials Research Part A. 2010;93(3):1080-1090
  82. 82. Sun G, Chen FA, Chu CC. Effects of precursor and cross-linking parameters on the properties of dextran-allyl isocyanate-ethylamine/poly(ethylene glycol diacrylate) biodegradable hydrogels and their release of ovalbumin. Journal of Biomaterials Science Polymer Edition. 2009;20(14):2003-2022
  83. 83. Askari M, Fisher C, Weniger FG, Bidic S, Lee WP. Anticoagulation therapy in microsurgery: A review. The Journal of Hand Surgery. 2006;31(5):836-846
  84. 84. Booi DI. Perioperative fluid overload increases anastomosis thrombosis in the free TRAM flap used for breast reconstruction. European Journal of Plastic Surgery. 2011;34(2):81-86
  85. 85. Gombocz K, Beledi A, Alotti N, Kecskés G, Gábor V, Bogár L, et al. Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations. Critical Care (London, England). 2007;11(4):R87
  86. 86. Steinbauer M, Harris AG, Messmer K. Effects of dextran on microvascular ischemia-reperfusion injury in striated muscle. The American Journal of Physiology. 1997;272(4 Pt 2):H1710-H1716
  87. 87. Sakamaki F, Hoffmann H, Müller C, Dienemann H, Messmer K, Schildberg FW. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation. American Journal of Respiratory and Critical Care Medicine. 1997;156(4 Pt 1):1073-1081
  88. 88. Banz Y, Gajanayake T, Matozan K, Yang Z, Rieben R. Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model. Journal of Vascular Surgery. 2009;50(1):161-170
  89. 89. Weng L, Romanov A, Rooney J, Chen W. Non-cytotoxic, in situ gelable hydrogels composed of N-carboxyethyl chitosan and oxidized dextran. Biomaterials. 2008;29(29):3905-3913
  90. 90. Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu B, Schacht E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials. 1998;19(18):1677-1687
  91. 91. Fan L, Lin C, Zhao P, Wen X, Li G. An injectable bioorthogonal dextran hydrogel for enhanced chondrogenesis of primary stem cells. Tissue Engineering Part C: Methods. 2018;24(9):504-513
  92. 92. Campos FS, Cassimiro DL, Crespi MS, Almeida AE, Gremião MPD. Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel. Brazilian Journal of Pharmaceutical Sciences. 2013;49:75-83
  93. 93. Zhang M, Huang Y, Pan W, Tong X, Zeng Q , Su T, et al. Polydopamine-incorporated dextran hydrogel drug carrier with tailorable structure for wound healing. Carbohydrate Polymers. 2021;253:117213
  94. 94. Ahmad S, Ahmad M, Manzoor K, Purwar R, Ikram S. A review on latest innovations in natural gums based hydrogels: Preparations & applications. International Journal of Biological Macromolecules. 2019;136:870-890
  95. 95. Mahmood H, Khan IU, Asif M, Khan RU, Asghar S, Khalid I, et al. In vitro and in vivo evaluation of gellan gum hydrogel films: Assessing the co impact of therapeutic oils and ofloxacin on wound healing. International Journal of Biological Macromolecules. 2021;166:483-495
  96. 96. Palumbo FS, Federico S, Pitarresi G, Fiorica C, Giammona G. Gellan gum-based delivery systems of therapeutic agents and cells. Carbohydrate Polymers. 2020;229:115430
  97. 97. Padil VVT, Cheong JY, Kp A, Makvandi P, Zare EN, Torres-Mendieta R, et al. Electrospun fibers based on carbohydrate gum polymers and their multifaceted applications. Carbohydrate Polymers. 2020;247:116705
  98. 98. Osmałek TZ, Froelich A, Soból M, Milanowski B, Skotnicki M, Kunstman P, et al. Gellan gum macrobeads loaded with naproxen: The impact of various naturally derived polymers on pH-dependent behavior. Journal of Biomaterials Applications. 2018;33(1):140-155
  99. 99. Choi JH, Park A, Lee W, Youn J, Rim MA, Kim W, et al. Preparation and characterization of an injectable dexamethasone-cyclodextrin complexes-loaded gellan gum hydrogel for cartilage tissue engineering. Journal of Controlled Release: Official Journal of the Controlled Release Society. 2020;327:747-765
  100. 100. Kim WK, Choi JH, Shin ME, Kim JW, Kim PY, Kim N, et al. Evaluation of cartilage regeneration of chondrocyte encapsulated gellan gum-based hyaluronic acid blended hydrogel. International Journal of Biological Macromolecules. 2019;141:51-59
  101. 101. Kim W, Choi JH, Kim P, Youn J, Song JE, Motta A, et al. Preparation and evaluation of gellan gum hydrogel reinforced with silk fibers with enhanced mechanical and biological properties for cartilage tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2021;15(11):936-947
  102. 102. Vuornos K, Huhtala H, Kääriäinen M, Kuismanen K, Hupa L, Kellomäki M, et al. Bioactive glass ions for in vitro osteogenesis and microvascularization in gellan gum-collagen hydrogels. Journal of Biomedical Materials Research Part B, Applied Biomaterials. 2020;108(4):1332-1342
  103. 103. Lopez-Heredia MA, Łapa A, Reczyńska K, Pietryga K, Balcaen L, Mendes AC, et al. Mineralization of gellan gum hydrogels with calcium and magnesium carbonates by alternate soaking in solutions of calcium/magnesium and carbonate ion solutions. Journal of Tissue Engineering and Regenerative Medicine. 2018;12(8):1825-1834
  104. 104. Bastos AR, da Silva LP, Maia FR, Pina S, Rodrigues T, Sousa F, et al. Lactoferrin-hydroxyapatite containing spongy-like hydrogels for bone tissue engineering. Materials (Basel, Switzerland). 2019;12(13):2074
  105. 105. Pereira D, Canadas R, Silva-Correia J, da Silva MA, Oliveira M, Dias I, et al. Injectable gellan-gum/hydroxyapatite-based bilayered hydrogel composites for osteochondral tissue regeneration. Applied Materials Today. 2018;12:309-321
  106. 106. Gomes ED, Ghosh B, Lima R, Goulão M, Moreira-Gomes T, Martins-Macedo J, et al. Combination of a gellan gum-based hydrogel with cell therapy for the treatment of cervical spinal cord injury. Frontiers in Bioengineering and Biotechnology. 2020;8:984
  107. 107. Rezvani Ghomi E, Khalili S, Nouri Khorasani S, Esmaeely Neisiany R, Ramakrishna S. Wound dressings: Current advances and future directions. Journal of Applied Polymer Science. 2019;136(27):47738
  108. 108. Shukla R, Kashaw SK, Jain AP, Lodhi S. Fabrication of apigenin loaded gellan gum-chitosan hydrogels (GGCH-HGs) for effective diabetic wound healing. International Journal of Biological Macromolecules. 2016;91:1110-1119
  109. 109. Si K, Jeon GY, Kim SE, Choe SH, Kim SJ, Seo JS, et al. Injectable hydrogel based on gellan gum/silk sericin for application as a retinal pigment epithelium cell carrier. ACS Omega. 2022;7(45):41331-41340
  110. 110. Bacelar AH, Silva-Correia J, Oliveira JM, Reis RL. Recent progress in gellan gum hydrogels provided by functionalization strategies. Journal of Materials Chemistry B. 2016;4(37):6164-6174
  111. 111. Kleinman HK, Martin GR. Matrigel: Basement membrane matrix with biological activity. Seminars in Cancer Biology. 2005;15(5):378-386
  112. 112. Corning Incorporated Life Sciences. Corning Matrigel Matrix Frequently Asked Questions. 2019. Available from: https://www.corningcom/catalog/cls/documents/faqs/CLS-DL-CC-026-A4pdf
  113. 113. Hughes CS, Postovit LM, Lajoie GA. Matrigel: A complex protein mixture required for optimal growth of cell culture. Proteomics. 2010;10(9):1886-1890
  114. 114. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Experimental Cell Research. 1992;202(1):1-8
  115. 115. Talbot NC, Caperna TJ. Proteome array identification of bioactive soluble proteins/peptides in Matrigel: Relevance to stem cell responses. Cytotechnology. 2015;67:873-883
  116. 116. Gillette KM, Forbes K, Sehgal I. Detection of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase-2, urokinase and plasminogen activator inhibitor-1 within matrigel and growth factor-reduced matrigel basement membrane. Tumori Journal. 2003;89(4):421-425
  117. 117. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology. 2001;19(10):971-974
  118. 118. Qian L, Saltzman WM. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials. 2004;25(7-8):1331-1337
  119. 119. Lee S-W, Lee HJ, Hwang HS, Ko K, Han DW, Ko K. Optimization of Matrigel-based culture for expansion of neural stem cells. Animal Cells and Systems. 2015;19(3):175-180
  120. 120. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology. 2007;25(9):1015-1024
  121. 121. Ponce ML. Tube formation: An in vitro matrigel angiogenesis assay. In: Angiogenesis Protocols. United States: Springer; 2009. pp. 183-188
  122. 122. Ponce ML. In vitro matrigel angiogenesis assays. Angiogenesis Protocols. 2001;46:205-209
  123. 123. Hocevar SE, Liu L, Duncan RK. Matrigel is required for efficient differentiation of isolated, stem cell-derived otic vesicles into inner ear organoids. Stem Cell Research. 2021;53:102295
  124. 124. Lugassy C, Zadran S, Bentolila L, Wadehra M, Prakash R, Carmichael S, et al. Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: An alternative to intravascular cancer dissemination. Cancer Microenviron. 2014;7(3):139, 101007/s1230.2014:7-014-152
  125. 125. Arnaoutova I, George J, Kleinman HK, Benton G. Basement membrane matrix (BME) has multiple uses with stem cells. Stem Cell Reviews and Reports. 2012;8:163-169
  126. 126. Gehrcke M, Martins CC, de Bastos BT, da Rosa LS, Luchese C, Wilhelm EA, et al. Novel pullulan/gellan gum bilayer film as a vehicle for silibinin-loaded nanocapsules in the topical treatment of atopic dermatitis. Pharmaceutics. 2022;14(11):2352
  127. 127. Benton G, Kleinman HK, George J, Arnaoutova I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. International Journal of Cancer. 2011;128(8):1751-1757
  128. 128. Scherzer T, Beckert A, Langguth H, Rummel S, Mehnert R. Electron beam curing of methacrylated gelatin. I. Dependence of the degree of crosslinking on the irradiation dose. Journal of Applied Polymer Science. 1997;63(10):1303-1312
  129. 129. Shie M-Y, Lee J-J, Ho C-C, Yen S-Y, Ng HY, Chen Y-W. Effects of gelatin methacrylate bio-ink concentration on mechano-physical properties and human dermal fibroblast behavior. Polymers. 2020;12(9):1930
  130. 130. Mei Q , Rao J, Bei HP, Liu Y, Zhao X. 3D bioprinting photo-crosslinkable hydrogels for bone and cartilage repair. International Journal of Bioprinting. 2021;7(3):367
  131. 131. Choi YH, Kim S-H, Kim I-S, Kim K, Kwon SK, Hwang NS. Gelatin-based micro-hydrogel carrying genetically engineered human endothelial cells for neovascularization. Acta Biomaterialia. 2019;95:285-296
  132. 132. Lindberg GC, Lim KS, Soliman BG, Nguyen A, Hooper GJ, Narayan RJ, et al. Biological function following radical photo-polymerization of biomedical polymers and surrounding tissues: Design considerations and cellular risk factors. Applied Physics Reviews. 2021;8(1):011301
  133. 133. Liu T, Weng W, Zhang Y, Sun X, Yang H. Applications of gelatin methacryloyl (GelMA) hydrogels in microfluidic technique-assisted tissue engineering. Molecules. 2020;25(22):5305
  134. 134. Rahali K, Ben Messaoud G, Kahn CJ, Sanchez-Gonzalez L, Kaci M, Cleymand F, et al. Synthesis and characterization of nanofunctionalized gelatin methacrylate hydrogels. International Journal of Molecular Sciences. 2017;18(12):2675
  135. 135. Wu J, Li G, Ye T, Lu G, Li R, Deng L, et al. Stem cell-laden injectable hydrogel microspheres for cancellous bone regeneration. Chemical Engineering Journal. 2020;393:124715
  136. 136. Fedorovich NE, Oudshoorn MH, van Geemen D, Hennink WE, Alblas J, Dhert WJ. The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials. 2009;30(3):344-353
  137. 137. Sun M, Sun X, Wang Z, Guo S, Yu G, Yang H. Synthesis and properties of gelatin methacryloyl (GelMA) hydrogels and their recent applications in load-bearing tissue. Polymers. 2018;10(11):1290
  138. 138. Wang Y, Zhang R, Qin W, Dai J, Zhang Q , Lee K, et al. Physicochemical properties of gelatin films containing tea polyphenol-loaded chitosan nanoparticles generated by electrospray. Materials & Design. 2020;185:108277
  139. 139. Liu J, Li L, Suo H, Yan M, Yin J, Fu J. 3D printing of biomimetic multi-layered GelMA/nHA scaffold for osteochondral defect repair. Materials & Design. 2019;171:107708
  140. 140. Alge DL, Anseth KS. Lighting the way. Nature Materials. 2013;12(11):950-952
  141. 141. Luo Y, Shoichet MS. A photolabile hydrogel for guided three-dimensional cell growth and migration. Nature Materials. 2004;3(4):249-253
  142. 142. West JL. Customized cell microenvironments. Nature Materials. 2011;10(10):727-729
  143. 143. Wu T, Gao YY, Su J, Tang XN, Chen Q , Ma LW, et al. Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink. Climacteric: The Journal of the International Menopause Society. 2022;25(2):170-178
  144. 144. Luo Z, Sun W, Fang J, Lee K, Li S, Gu Z, et al. Biodegradable gelatin methacryloyl microneedles for transdermal drug delivery. Advanced Healthcare Materials. 2019;8(3):1801054
  145. 145. Lee K, Xue Y, Lee J, Kim H, Liu Y, Tebon P, et al. A patch of detachable hybrid microneedle depot for localized delivery of mesenchymal stem cells in regeneration therapy. Advanced Functional Materials. 2020;30:2000086
  146. 146. Qu M, Kim H-J, Zhou X, Wang C, Jiang X, Zhu J, et al. Biodegradable microneedle patch for transdermal gene delivery. Nanoscale. 2020;12(32):16724-16729
  147. 147. Caudill C, Perry JL, Iliadis K, Tessema AT, Lee BJ, Mecham BS, et al. Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. Proceedings of the National Academy of Sciences. 2021;118(39):e2102595118
  148. 148. Chi J, Zhang X, Chen C, Shao C, Zhao Y, Wang Y. Antibacterial and angiogenic chitosan microneedle array patch for promoting wound healing. Bioactive Materials. 2020;5(2):253-259
  149. 149. Barnum L, Samandari M, Schmidt TA, Tamayol A. Microneedle arrays for the treatment of chronic wounds. Expert Opinion on Drug Delivery. 2020;17(12):1767-1780
  150. 150. Zhang X, Hasani-Sadrabadi MM, Zarubova J, Dashtimighadam E, Haghniaz R, Khademhosseini A, et al. Immunomodulatory microneedle patch for periodontal tissue regeneration. Matter. 2022;5(2):666-682
  151. 151. Su G, Li G, Wang W, Xu L. Application Prospect and preliminary exploration of GelMA in corneal stroma regeneration. Polymers. 2022;14(19):4227
  152. 152. Man K, Barroso IA, Brunet MY, Peacock B, Federici AS, Hoey DA, et al. Controlled release of epigenetically-enhanced extracellular vesicles from a GelMA/Nanoclay composite hydrogel to promote bone repair. International Journal of Molecular Sciences. 2022;23(2):832
  153. 153. Hashemi S, Mondal D, Montesano J, Willett TL. Effects of biopolymer functionalization and nanohydroxyapatite heat treatment on the tensile and thermomechanical properties of bone-inspired 3D printable nanocomposite biomaterials. Materials & Design. 2023;225:111587
  154. 154. Zhang L, Li T, Yu Y, Shi K, Bei Z, Qian Y, et al. An injectable conductive hydrogel restores electrical transmission at myocardial infarct site to preserve cardiac function and enhance repair. Bioactive Materials. 2023;20:339-354
  155. 155. Wu T, Liu W. Functional hydrogels for the treatment of myocardial infarction. NPG Asia Materials. 2022;14(1):9
  156. 156. Haghniaz R, Kim H-J, Montazerian H, Baidya A, Tavafoghi M, Chen Y, et al. Tissue adhesive hemostatic microneedle arrays for rapid hemorrhage treatment. Bioactive Materials. 2023;23:314-327
  157. 157. Li S, Sun J, Yang J, Yang Y, Ding H, Yu B, et al. Gelatin methacryloyl (GelMA) loaded with concentrated hypoxic pretreated adipose-derived mesenchymal stem cells(ADSCs) conditioned medium promotes wound healing and vascular regeneration in aged skin. Biomaterials Research. 2023;27:11
  158. 158. Zhao W, Zhu J, Hang J, Zeng W. Biomaterials to promote vascularization in tissue engineering organs and ischemic fibrotic diseases. MedComm–Biomaterials and Applications. 2022;1(1):e16
  159. 159. Rahmani S, Maroufkhani M, Mohammadzadeh-Komuleh S, Khoubi-Arani Z. Chapter 7- Polymer nanocomposites for biomedical applications. In: Barhoum A, Jeevanandam J, Danquah MK, editors. Fundamentals of Bionanomaterials. Amsterdam, Netherlands: Elsevier; 2022. pp. 175-215
  160. 160. Lee JM, Ma WC, Yeong WY. Chapter 7 - Hydrogels for bioprinting. In: Zhang LG, Fisher JP, Leong KW, editors. 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine. 2nd ed. United States: Academic Press; 2022. pp. 185-211
  161. 161. Hamid ZA, Lim K. Evaluation of UV-crosslinked poly (ethylene glycol) diacrylate/poly (dimethylsiloxane) dimethacrylate hydrogel: Properties for tissue engineering application. Procedia Chemistry. 2016;19:410-418
  162. 162. Peppas NA, Keys KB, Torres-Lugo M, Lowman AM. Poly (ethylene glycol)-containing hydrogels in drug delivery. Journal of Controlled Release. 1999;62(1-2):81-87
  163. 163. Zhu J. Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering. Biomaterials. 2010;31(17):4639-4656
  164. 164. Skardal A, Zhang J, Prestwich GD. Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. Biomaterials. 2010;31(24):6173-6181
  165. 165. Kamaraj M, Sreevani G, Prabusankar G, Rath SN. Mechanically tunable photo-cross-linkable bioinks for osteogenic differentiation of MSCs in 3D bioprinted constructs. Materials Science and Engineering: C. 2021;131:112478
  166. 166. Cui X, Breitenkamp K, Finn M, Lotz M, D'Lima DD. Direct human cartilage repair using three-dimensional bioprinting technology. Tissue Engineering Part A. 2012;18(11-12):1304-1312
  167. 167. Laurienzo P, Malinconico M, Motta A, Vicinanza A. Synthesis and characterization of a novel alginate–poly (ethylene glycol) graft copolymer. Carbohydrate Polymers. 2005;62(3):274-282
  168. 168. Jeon O, Samorezov JE, Alsberg E. Single and dual crosslinked oxidized methacrylated alginate/PEG hydrogels for bioadhesive applications. Acta Biomaterialia. 2014;10(1):47-55
  169. 169. Olthof MG, Kempen DH, Liu X, Dadsetan M, Tryfonidou MA, Yaszemski MJ, et al. Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel. Journal of Tissue Engineering and Regenerative Medicine. 2018;12(6):1339-1351
  170. 170. Liu X, Fundora KA, Zhou Z, Miller AL, Lu L. Composite hydrogel embedded with porous microspheres for long-term pH-sensitive drug delivery. Tissue Engineering Part A. 2019;25(3-4):172-182
  171. 171. Chimene D, Kaunas R, Gaharwar AK. Hydrogel bioink reinforcement for additive manufacturing: A focused review of emerging strategies. Advanced Materials. 2020;32(1):1902026
  172. 172. Deshmukh K, Basheer Ahamed M, Deshmukh RR, Khadheer Pasha SK, Bhagat PR, Chidambaram K. 3 - Biopolymer composites with high dielectric performance: Interface engineering. In: Sadasivuni KK, Ponnamma D, Kim J, Cabibihan JJ, AlMaadeed MA, editors. Biopolymer Composites in Electronics. Amsterdam, Netherlands: Elsevier; 2017. pp. 27-128
  173. 173. Woodruff MA, Hutmacher DW. The return of a forgotten polymer—Polycaprolactone in the 21st century. Progress in Polymer Science. 2010;35(10):1217-1256
  174. 174. Más Estellés J, Vidaurre A, Meseguer Dueñas JM, Castilla CI. Physical characterization of polycaprolactone scaffolds. Journal of Materials Science: Materials in Medicine. 2008;19:189-195
  175. 175. Alix S, Mahieu A, Terrie C, Soulestin J, Gerault E, Feuilloley MGJ, et al. Active pseudo-multilayered films from polycaprolactone and starch based matrix for food-packaging applications. European Polymer Journal. 2013;49(6):1234-1242
  176. 176. Das GS, Rao GH, Wilson RF, Chandy T. Colchicine encapsulation within poly (ethylene glycol)-coated poly (lactic acid)/poly (?-caprolactone) microspheres-controlled release studies. Drug Delivery. 2000;7(3):129-138
  177. 177. Dordunoo SK, Jackson JK, Arsenault LA, Oktaba AMC, Hunter WL, Burt HM. Taxol encapsulation in poly (ɛ-caprolactone) microspheres. Cancer Chemotherapy and Pharmacology. 1995;36:279-282
  178. 178. Chang R-K, Price JC, Whitworth CW. Dissolution characteristics of polycaprolactone-polylactide microspheres of chlorpromazine. Drug Development and Industrial Pharmacy. 1986;12(14):2355-2380
  179. 179. Carreras N, Acuña V, Martí M, Lis M. Drug release system of ibuprofen in PCL-microspheres. Colloid and Polymer Science. 2013;291(1):157-165
  180. 180. Giunchedi P, Conti B, Maggi L, Conte U. Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. Journal of Microencapsulation. 1994;11(4):381-393
  181. 181. Perez MH, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, et al. The preparation and evaluation of poly (ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. Journal of Controlled Release. 2000;65(3):429-438
  182. 182. Radhakrishnan S, Nagarajan S, Belaid H, Farha C, Iatsunskyi I, Coy E, et al. Fabrication of 3D printed antimicrobial polycaprolactone scaffolds for tissue engineering applications. Materials Science and Engineering: C. 2021;118:111525
  183. 183. Mogoşanu GD, Grumezescu AM. Natural and synthetic polymers for wounds and burns dressing. International Journal of Pharmaceutics. 2014;463(2):127-136
  184. 184. Zopf DA, Flanagan CL, Wheeler M, Hollister SJ, Green GE. Treatment of severe porcine tracheomalacia with a 3-dimensionally printed, bioresorbable, external airway splint. JAMA Otolaryngology–Head & Neck Surgery. 2014;140(1):66-71
  185. 185. Kankala RK, Zhu K, Li J, Wang C-S, Wang S-B, Chen A-Z. Fabrication of arbitrary 3D components in cardiac surgery: From macro-, micro-to nanoscale. Biofabrication. 2017;9(3):032002
  186. 186. Hendow EK, Guhmann P, Wright B, Sofokleous P, Parmar N, Day RM. Biomaterials for hollow organ tissue engineering. Fibrogenesis & Tissue Repair. 2016;9(1):1-7
  187. 187. Rasperini G, Pilipchuk S, Flanagan C, Park C, Pagni G, Hollister S, et al. 3D-printed bioresorbable scaffold for periodontal repair. Journal of Dental Research. 2015;94(9_suppl):153S-157S
  188. 188. Hiremath P, Nuguru K, Agrahari V. Chapter 8 - Material attributes and their impact on wet granulation process performance. In: Narang AS, Badawy SIF, editors. Handbook of Pharmaceutical Wet Granulation. United States: Academic Press; 2019. pp. 263-315
  189. 189. Folttmann H, Quadir A. Polyvinylpyrrolidone (PVP)—One of the most widely used excipients in pharmaceuticals: An overview. Drug Delivery Technology. 2008;8(6):22-27
  190. 190. Bothiraja C, Shinde MB, Rajalakshmi S, Pawar AP. Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide—PVP. Journal of Pharmacy and Pharmacology. 2009;61(11):1465-1472
  191. 191. Rasekh M, Karavasili C, Soong YL, Bouropoulos N, Morris M, Armitage D, et al. Electrospun PVP–indomethacin constituents for transdermal dressings and drug delivery devices. International Journal of Pharmaceutics. 2014;473(1-2):95-104
  192. 192. del Consuelo ID, Falson F, Guy RH, Jacques Y. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. Journal of Controlled Release. 2007;122(2):135-140
  193. 193. Zhang L, Liang Y, Meng L, Wang C. Characterization of complexation of PVP copolymer with DNA. Polymers for Advanced Technologies. 2009;20(4):410-415
  194. 194. Song Y, Zhang T, Song X, Zhang L, Zhang C, Xing J, et al. Polycations with excellent gene transfection ability based on PVP-g-PDMAEMA with random coil and micelle structures as non-viral gene vectors. Journal of Materials Chemistry B. 2015;3(5):911-918
  195. 195. Saxena A, Mozumdar S, Johri AK. Ultra-low sized cross-linked polyvinylpyrrolidone nanoparticles as non-viral vectors for in vivo gene delivery. Biomaterials. 2006;27(32):5596-5602
  196. 196. Benamer S, Mahlous M, Boukrif A, Mansouri B, Youcef SL. Synthesis and characterisation of hydrogels based on poly(vinyl pyrrolidone). Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 2006;248(2):284-290
  197. 197. Daniele MA, Adams AA, Naciri J, North SH, Ligler FS. Interpenetrating networks based on gelatin methacrylamide and PEG formed using concurrent thiol click chemistries for hydrogel tissue engineering scaffolds. Biomaterials. 2014;35(6):1845-1856
  198. 198. An J, Teoh JEM, Suntornnond R, Chua CK. Design and 3D printing of scaffolds and tissues. Engineering. 2015;1(2):261-268
  199. 199. Yoshida K, Sakurai Y, Kawahara S, Takeda T, Ishikawa T, Murakami T, et al. Anaphylaxis to polyvinylpyrrolidone in povidone-iodine for impetigo contagiosum in a boy with atopic dermatitis. International Archives of Allergy and Immunology. 2008;146(2):169-173
  200. 200. Adachi A, Fukunaga A, Hayashi K, Kunisada M, Horikawa T. Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine. Contact Dermatitis. 2003;48(3):133-136
  201. 201. Rönnau AC, Wulferink M, Gleichmann E, Unver E, Ruzicka T, Krutmann J, et al. Anaphylaxis to polyvinylpyrrolidone in an analgesic preparation. British Journal of Dermatology. 2000;143(5):1055-1058
  202. 202. York KK, Miller S, Gaster RN, Burstein NL. Polyvinylpyrrolidone iodine: Corneal toxicology and epithelial healing in a rabbit model. Journal of Ocular Pharmacology and Therapeutics. 1988;4(4):351-358
  203. 203. Adsul MG, Varma AJ, Gokhale DV. Lactic acid production from waste sugarcane bagasse derived cellulose. Green Chemistry. 2007;9(1):58-62
  204. 204. Singhvi M, Joshi D, Adsul M, Varma A, Gokhale D. d-(−)-Lactic acid production from cellobiose and cellulose by lactobacillus lactis mutant RM2-2 4. Green Chemistry. 2010;12(6):1106-1109
  205. 205. Datta R, Tsai S-P, Bonsignore P, Moon S-H, Frank JR. Technological and economic potential of poly (lactic acid) and lactic acid derivatives. FEMS Microbiology Reviews. 1995;16(2-3):221-231
  206. 206. Gupta B, Revagade N, Hilborn J. Poly (lactic acid) fiber: An overview. Progress in Polymer Science. 2007;32(4):455-482
  207. 207. Graupner N, Herrmann AS, Müssig J. Natural and man-made cellulose fibre-reinforced poly (lactic acid)(PLA) composites: An overview about mechanical characteristics and application areas. Composites Part A: Applied Science and Manufacturing. 2009;40(6-7):810-821
  208. 208. Dutkiewicz S, Grochowska-Łapienis D, Tomaszewski W. Synthesis of poly (L (+) lactic acid) by polycondensation method in solution. Fibres & Textiles in Eastern Europe. 2003;4(43):66-70
  209. 209. Terzopoulou Z, Zamboulis A, Bikiaris DN, Valera MA, Mangas A. Synthesis, properties, and enzymatic hydrolysis of poly(lactic acid)-co-poly(propylene adipate) block copolymers prepared by reactive extrusion. Polymers. 2021;13(23):4121
  210. 210. Chen G, Ushida T, Tateishi T. Scaffold design for tissue engineering. Macromolecular Bioscience. 2002;2(2):67-77
  211. 211. Lasprilla AJR, Martinez GAR, Lunelli BH, Jardini AL, Filho RM. Poly-lactic acid synthesis for application in biomedical devices — A review. Biotechnology Advances. 2012;30(1):321-328
  212. 212. Casalini T, Rossi F, Castrovinci A, Perale G. A perspective on polylactic acid-based polymers use for nanoparticles synthesis and applications. Frontiers in Bioengineering and Biotechnology. 2019;7:259
  213. 213. Callahan LAS, Xie S, Barker IA, Zheng J, Reneker DH, Dove AP, et al. Directed differentiation and neurite extension of mouse embryonic stem cell on aligned poly (lactide) nanofibers functionalized with YIGSR peptide. Biomaterials. 2013;34(36):9089-9095
  214. 214. Kurobe H, Maxfield MW, Tara S, Rocco KA, Bagi PS, Yi T, et al. Development of small diameter nanofiber tissue engineered arterial grafts. PLoS One. 2015;10(4):e0120328
  215. 215. Mohiti-Asli M, Pourdeyhimi B, Loboa EG. Skin tissue engineering for the infected wound site: Biodegradable PLA nanofibers and a novel approach for silver ion release evaluated in a 3D coculture system of keratinocytes and Staphylococcus aureus. Tissue Engineering Part C: Methods. 2014;20(10):790-797
  216. 216. Raquez J-M, Habibi Y, Murariu M, Dubois P. Polylactide (PLA)-based nanocomposites. Progress in Polymer Science. 2013;38(10-11):1504-1542
  217. 217. Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. International Journal of Molecular Sciences. 2014;15(3):3640-3659
  218. 218. Gupta A, Kumar V. New emerging trends in synthetic biodegradable polymers–polylactide: A critique. European Polymer Journal. 2007;43(10):4053-4074
  219. 219. Mir M, Ahmed N, ur Rehman A. Recent applications of PLGA based nanostructures in drug delivery. Colloids and Surfaces B: Biointerfaces. 2017;159:217-231
  220. 220. Passerini N, Craig D. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. Journal of Controlled Release. 2001;73(1):111-115
  221. 221. Engineer C, Parikh J, Raval A. Review on hydrolytic degradation behavior of biodegradable polymers from controlled drug delivery system. Trends in Biomaterials & Artificial Organs. 2011;25(2):79-85
  222. 222. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377-1397
  223. 223. Sharma S, Parmar A, Kori S, Sandhir R. PLGA-based nanoparticles: A new paradigm in biomedical applications. TrAC Trends in Analytical Chemistry. 2016;80:30-40
  224. 224. Alkahtani S, Alarifi S, Albasher G, Al-Zharani M, Aljarba NH, Almarzoug MH, et al. Poly lactic-co-glycolic acid- (PLGA-) loaded nanoformulation of cisplatin as a therapeutic approach for breast cancers. Oxidative Medicine and Cellular Longevity. 2021;2021:5834418
  225. 225. Lee PW, Pokorski JK. Poly(lactic-co-glycolic acid) devices: Production and applications for sustained protein delivery. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2018;10(5):e1516
  226. 226. Yu Y, Sun B, Yi C, Mo X. Stem cell homing-based tissue engineering using bioactive materials. Frontiers of Materials Science. 2017;11:93-105
  227. 227. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cell. 2019;8(8):886
  228. 228. Pourentezari M, Dortaj H, Hashemibeni B, Yadegari M, Shahedi A. An overview of the application of poly(lactic-co-glycolic) acid (PLGA)-based scaffold for drug delivery in cartilage tissue engineering. International Journal of Medical Laboratory. 2021;8(2):78-95

Written By

Arezou Pezhman

Submitted: 12 February 2024 Reviewed: 20 February 2024 Published: 24 May 2024